Document is current

Article History

Accepted: 19 October 2023

First Online: 17 November 2023

Compliance with Ethical Standards

:

: This article does not contain any studies with human or animal subjects performed by any of the authors.

: AJ declares no conflicts of interest. HO’S has received honorarium from Amgen and AstraZeneca and expenses from Takeda, all outside the scope of the submitted work. SP reports consulting fees/honoraria from: Amgen, AstraZeneca, Bayer, Blueprint, BMS, Boehringer Ingelheim, Daiichi EQRX, Sankyo, GSK, Guardant Health, Incyte, Janssen, Lilly, Merck Serono, MSD, Novartis, Roche, Takeda, Pfizer, Seattle Genetics, and Turning Point Therapeutics.